Insider holders · CIK 0001819133
Tango Therapeutics, Inc. · TNGX
Every insider with a reported Table I holding at this company, ranked by their last-reported share count. A balance is only as fresh as its filing — the report date sits next to every row on purpose. ← Back to activity
| Insider | Direct shares | Indirect shares | Total reported | Last report (ET) | From |
|---|---|---|---|---|---|
| Adam CrystalPresident, R&D | 115,743 | — | 115,743 | Sep 3, 2026 · 4:01 pm EDT | Form 4 |
| Jessica NewcombPrincipal Accounting Officer | 59,121 | — | 59,121 | Sep 24, 2026 · 7:41 pm EDT | Form 4 |
| Mace RothenbergDirector | 41,500 | — | 41,500 | Jun 8, 2026 · 5:55 pm EDT | Form 4 |
| John B KetchumDirector | 24,937 | — | 24,937 | Jun 8, 2026 · 6:08 pm EDT | Form 4 |
| Sung LeeDirector | 22,870 | — | 22,870 | Jun 8, 2026 · 5:49 pm EDT | Form 4 |
| Lesley Ann CalhounDirector | 16,500 | — | 16,500 | Jun 8, 2026 · 6:01 pm EDT | Form 4 |
| Robert AzelbyDirector | 5,740 | — | 5,740 | Jun 23, 2026 · 6:10 pm EDT | Form 4 |
Balances come from each insider’s most recent filing that reports a Table I holding; an insider who left the company years ago still appears with their last-known figure and its date. Indirect totals collapse multiple vehicles (trusts, LLCs) into one number — open the filing for the breakdown. Shares as filed, not split-adjusted.